共 11 条
[2]
Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15; High-Sensitivity C-Reactive Protein; Galectin-3; and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure.[J].Dirk J. Lok;IJsbrand T. Klip;Sjoukje I. Lok;Pieta W. Bruggink-André de la Porte;Erik Badings;Jan van Wijngaarden;Adriaan A. Voors;Rudolf A. de Boer;Dirk J. van Veldhuisen;Peter van der Meer.The American Journal of Cardiology.2013,
[3]
The fibrosis marker galectin‐3 and outcome in the general population.[J].R. A. de Boer;D. J. van Veldhuisen;R. T. Gansevoort;A. C. Muller Kobold;W. H. van Gilst;H. L. Hillege;S. J. L. Bakker;P. van der Harst.Journal of Internal Medicine.2011, 1
[4]
Cardiac biomarkers – the old and the new: a review.[J]..Coronary Artery Disease.2010, 4
[6]
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.[J].Yen-Hung Lin;Lian-Yu Lin;Yen-Wen Wu;Kuo-Liong Chien;Chi-Ming Lee;Ron-Bin Hsu;Chia-Lun Chao;Shoei-Shen Wang;Yenh-Chen Hsein;Lin-Chu Liao;Yi-Lwun Ho;Ming-Fong Chen.Clinica Chimica Acta.2009, 1
[10]
Expression and immunohistochemical localization of galectin-3 in various mouse tissues.[J].Heechul Kim;Jeeyoung Lee;Jin Won Hyun;Jae Woo Park;Hong-gu Joo;Taekyun Shin.Cell Biology International.2006, 7

